Profile	GDS3514 / 209733_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	354.215	51
GSM325241	Patient no. 1: treated	240.266	43
GSM325242	Patient no. 9: control	353.249	52
GSM325243	Patient no. 9: treated	329.426	51
GSM325244	Patient no. 18: control	341.879	46
GSM325245	Patient no. 18: treated	289.75	43
GSM325246	Patient no. 12: control	116.376	32
GSM325247	Patient no. 12: treated	126.201	35
GSM325248	Patient no. 3: control	342.052	52
GSM325249	Patient no. 3: treated	357.514	53
GSM325250	Patient no. 7: control	262.234	49
GSM325251	Patient no. 7: treated	167.58	41
GSM325252	Patient no. 15: control	366.981	51
GSM325253	Patient no. 15: treated	354.549	50
GSM325254	Patient no. 4: control	501.799	59
GSM325255	Patient no. 4: treated	418.392	54
GSM325256	Patient no. 19: control	120.916	31
GSM325257	Patient no. 19: treated	132.812	34
GSM325258	Patient no. 14: control	332.494	50
GSM325259	Patient no. 14: treated	354.319	48
GSM325260	Patient no. 13: control	374.642	51
GSM325261	Patient no. 13: treated	562.908	60
GSM325262	Patient no. 17: control	211.469	40
GSM325263	Patient no. 17: treated	200.162	36
GSM325264	Patient no. 10: control	431.363	56
GSM325265	Patient no. 10: treated	439.771	56
GSM325266	Patient no. 5: control	152.649	38
GSM325267	Patient no. 5: treated	139.055	41
GSM325268	Patient no. 11: control	585.147	60
GSM325269	Patient no. 11: treated	210.763	42
GSM325270	Patient no. 6: control	886.693	70
GSM325271	Patient no. 6: treated	238.48	46
GSM325272	Patient no. 8: control	975.108	73
GSM325273	Patient no. 8: treated	533.444	61
GSM325274	Patient no. 16: control	357.685	51
GSM325275	Patient no. 16: treated	263.111	47
GSM325276	Patient no. 2: control	826.231	67
GSM325277	Patient no. 2: treated	341.222	56